USA flag logo/image

An Official Website of the United States Government

NON-ISOTOPIC MONOCLONAL IMMUNOASSAY FOR FENTANYL ANALOGS

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
8134
Program Year/Program:
1988 / SBIR
Agency Tracking Number:
8134
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
American Monitor Corp
Box 68505 Indianapolis, IN 46268
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1988
Title: NON-ISOTOPIC MONOCLONAL IMMUNOASSAY FOR FENTANYL ANALOGS
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

THE LONG TERM OBJECTIVE IS TO DEVELOP A HIGHLY AUTOMATED FLUORESCENCE POLARIZATION IMMUNOASSAY (FPIA) FOR FENTANYL AND ANALOGS. THE PHASE I SPECIFIC AIM IS TO SYNTHESIZE AND EVALUATE: 1) FLUORESCEIN LABELED FENTANYL ANALOGS USABLE IN A FPIA; 2) FENTANYL (HAPTEN) - PROTEIN CONJUGATES USED TO ELICIT AN IMMUNE RESPONSE IN BALB/C MICE; 3) MURINE MONOCLONAL ANTIBODIES TO FENTANYL AND ANALOGS. THE PHASE I OBJECTIVE IS TWOFOLD: 1) TO CHOOSE FROM THE SYNTHETIC COMPONENTS A BEST COMBINATION FOR MEASURING FENTANYL AND ANALOGS; 2) TO PREPARE A SMALL "BANK" OF WELL CHARACTERIZED MURINE MONOCLONAL ANTIBODIES FOR INTERNAL USE AS WELL AS FOR USE BY OTHER INVESTIGATORS. THE HEALTHCARE INDUSTRY AND LEGISLATORS ARE ILL PREPARED FORTHE RAPID AND COMPLEX IMPACT OF ESCALATING FENTANYL ABUSE. THE NEED OF AN INNOVATIVE APPROACH FOR DETECTING FENTANYL INBLOOD OR URINE IS GENERALLY RECOGNIZED. AUTHORITIES AGREE THAT AN IMMUNOASSAY WILL BE REQUIRED. BY PROVIDING A FLUORESCENCE POLARIZATION IMMUNOASSAY FOR FENTANYL AND ANALOGS, THE DRAWBACKS ASSOCIATED WITH RADIOIMMUNOASSAY WILL BE OVERCOME.

Principal Investigator:


0

Business Contact:

Small Business Information at Submission:

American Monitor Corp
Box 68505 Indianapolis, IN 46268

EIN/Tax ID:
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No